文献速递中医内科中医康复

温和灸对5-氟尿嘧啶诱导肠黏膜炎大鼠肠道菌群及NLRP3炎症小体的影响

Effects of mild moxibustion on intestinal microbiome and NLRP3 inflammasome in rats with 5-fluorouracil-induced intestinal mucositis.
PubMed 文献 · J Integr Med · 2020-12-05

本研究在5-氟尿嘧啶诱导的肠黏膜炎大鼠模型中观察温和灸对肠道菌群及NLRP3炎症小体的影响。结果显示艾灸与益生菌均能改善黏膜损伤、降低炎症、调节菌群,且艾灸可能通过下调NLRP3炎症小体发挥作用。

要点

  • 温和灸可改善5-Fu诱导肠黏膜炎大鼠的黏膜损伤并降低炎症。
  • 艾灸能调节肠道菌群α/β多样性及乳杆菌、罗斯氏菌和埃希菌丰度。
  • 艾灸疗效可能与下调NLRP3炎症小体相关蛋白表达有关。

核心结论

  • 温和灸通过改善黏膜损伤和减轻炎症对肠黏膜炎发挥治疗作用。
  • 艾灸可能通过下调NLRP3炎症小体表达来调节肠道菌群。

研究设计与样本

  • 肠黏膜炎模型通过腹腔注射5-氟尿嘧啶建立。
  • 温和灸和益生菌灌胃每日一次,持续15天。

主要发现

  • 艾灸和益生菌均显著增加紧密连接蛋白表达,减少细胞凋亡及caspase-1、gasdermin D和NLRP3表达。
  • 艾灸和益生菌降低血清TNF-α、IL-6、IL-1β和IL-18水平,升高IL-10水平。
  • 艾灸和益生菌纠正肠黏膜炎大鼠α多样性和β多样性降低,增加乳杆菌属比例,降低罗斯氏菌属和埃希菌属丰度至健康动物水平。
  • 优势菌属与焦亡相关蛋白及炎症因子调控密切相关。
  • 艾灸和益生菌在调节肠道宿主-微生物稳态及NLRP3炎症小体相关因子表达方面效果相似。

临床怎么用

  • 对于5-Fu化疗相关肠黏膜炎,温和灸可能作为改善黏膜损伤和炎症的辅助疗法。
  • 艾灸调节肠道菌群和NLRP3炎症小体的作用提示其潜在机制,但需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The present study investigated how mild moxibustion treatment affects the intestinal microbiome and expression of NLRP3-related immune factors in a rat model of intestinal mucositis (IM) induced with 5-fluorouracil (5-Fu). METHODS: Forty male Sprague-Dawley rats were randomly divided into control, chemotherapy, moxibustion and probiotics groups. The IM rat model was established by intraperitoneal injection of 5-Fu. Mild moxibustion treatment and intragastric probiotic administration were provided once daily for 15 days. Tissue morphology, serum levels of inflammatory factors and the expression levels of tight junction proteins, caspase-1, gasdermin D and NLRP3 were evaluated in colon tissue, through hematoxylin and eosin staining, electron microscopy, enzyme-linked immunosorbent assay, Western blotting, quantitative real-time reverse transcription polymerase chain reaction and immunofluorescence. Gut microbiome profiling was conducted through 16S rRNA amplicon sequencing. RESULTS: Moxibustion and probiotic treatments significantly increased the expression levels of tight junction proteins, reduced cell apoptosis and the expression levels of caspase-1, gasdermin D and NLRP3; they also decreased the serum levels of tumor necrosis factor-α, interleukin (IL)-6, IL-1β and IL-18, while increasing serum levels of IL-10. Moxibustion and probiotic treatments also corrected the reduction in α-diversity and β-diversity in IM rats, greatly increased the proportion of the dominant bacterial genus Lactobacillus and reduced the abundance of the genera Roseburia and Escherichia in chemotherapy-treated rats to levels observed in healthy animals. We also found that these dominant genera were firmly correlated with the regulation of pyroptosis-associated proteins and inflammatory factors. Finally, moxibustion and probiotic treatments elicited similar effects in regulating intestinal host-microbial homeostasis and the expression of NLRP3 inflammasome-related factors. CONCLUSION: Moxibustion exerts its therapeutic effect on IM by ameliorating mucosal damage and reducing inflammation. Moreover, moxibustion modulates the gut microbiota, likely via decreasing the expression levels of the NLRP3 inflammasome.

来源:J Integr Med,查看原文。版权归原作者所有。

引用

  1. Li BR, Shao SY, Yuan L, et al. Effects of mild moxibustion on intestinal microbiome and NLRP3 inflammasome in rats with 5-fluorouracil-induced intestinal mucositis. J Integr Med. 2020. PMID: 33353843. doi:10.1016/j.joim.2020.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。